I particularly like the comparison with stoke therapeutics with a 1.6b mcap and seemingly they have a platform and 3 assets in development. Isn't that close to where we are? Sure they have more cash, but.....
someone bidding a million at 46 must be thinking the same..
Add to My Watchlist
What is My Watchlist?